Interstitial cystitis (IC) is a chronic bladder inflammatory disease of unknown etiology that shares similarities with Crohn's disease and psoriasis. IC, often regarded as a neurogenic cystitis, is associated with urothelial lesions that likely compromise the bladder permeability barrier and thereby contribute to patient morbidity. Here we use a murine model of neurogenic cystitis to investigate the mechanism of urothelial lesion formation and find that urothelial apoptosis induces formation of lesions. Lesions formed in wild-type mice but not in mice deficient in TNF, TNF receptors, or mast cells.
INTRODUCTION
Interstitial cystitis (IC), also known as painful bladder syndrome, is a chronic bladder inflammatory disease with unknown etiology that afflicts nearly 1 million patients in the United States, with women comprising ~90% of the cases (23, 36, 40) . IC is often considered a neurogenic cystitis due to both voiding dysfunction and to the partial efficacy of sacral nerve stimulation or neuropharmacologic therapies in some patients.
The diagnosis of IC requires the finding of lesions in the urothelium upon cystoscopic examination (17) . In the more severe form, the lesions may appear as a large ulceration present in less than 10% of patients (49) , but the majority of patients present with punctate urothelial hemorrhages, termed as glomerulations, observed following hydrodistension. Cats suffer a similar disease, feline IC (FIC), associated with voiding dysfunction and behavioral symptoms of pelvic pain. Although the feline disease does not exhibit the strong gender bias of the human disease, FIC is also characterized by urothelial ulcerations (6, 7) . Microscopic evaluation of FIC bladder tissues provides a cellular basis for the urothelial lesion: scanning and transmission electron microscopy revealed disruptions of the normal urothelial apical membrane and tight junction morphology (31) . In both the human and feline diseases, the mechanism of urothelial lesion formation is unknown.
It has been suggested that urothelial lesions contribute to decreased bladder barrier function (15) . By allowing noxious urine components to cross the permeability barrier normally provided by intact urothelium, these lesions may result in the activation of sensory nerves and thus contribute to pain and voiding dysfunction. Consistent with this hypothesis, FIC cats show decreased bladder barrier function compared to normal cats that correlate with urothelial lesions (31) .
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Several mechanisms have been proposed for the bladder defects in IC, including a urinary anti-proliferative factor (APF) and a neuro-immune interaction involving mast cells (14, 24) . The APF hypothesis is supported by findings that urine of IC patients contains a glycopeptide that inhibits urothelial proliferation in vitro (25, 26) . Alternatively, mast cells are thought to play a role in the pathogenesis of IC for at least some patients because a subset of IC patients have elevated counts of bladder mast cells that often appear partially activated and juxtaposed with sensory nerves (34, 42, 50). In this neuroimmune model, it is hypothesized that inflammatory mediators released by mast cells result in urothelial damage, and increased concentrations of methylhistamine and mast cell-specific tryptase have been detected in urine of IC patients (5, 13).
Mast cells have shown to mediate bladder inflammation in various rodent cystitis models. For example, instillation of substance P or lipopolysaccharide into the bladder via transurethral catheter resulted in cystitis that included leukocyte influx and vascular permeability (4, 41) . In both models, cystitis was not observed in mast cell-deficient (W/W v ) mice, but sensitivity was restored upon reconstitution with WT bone marrow. At least some effects of mast cells in the bladder may be mediated by TNF, since mast cells were shown to directly induce urothelial inflammatory responses, and anti-TNF antibodies abrogated the urothelial responses in culture (3). Mast cells have been further implicated in bladder pathogenesis in a rat neurogenic cystitis model that employs the attenuated Bartha's strain of pseudorabies virus (PRV) to activate bladder afferents strictly via central mechanisms. Jasmin and colleagues observed that rats developed a cystitis associated with mast cell influx and urinary histamine metabolites (21, 22) . Thus, mast cells play a role in several cystitis models, including a centrallymediated neurogenic cystitis that mimics aspects of IC.
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We recently adapted the PRV-induced neurogenic cystitis model to the murine system to take advantage of more abundant genetic tools. We reported that PRV induced a neurogenic cystitis in mice that increased vascular permeability, induced leukocyte influx, and resulted in differential trafficking of mast cell pools within the bladder (10) . Further, these events did not occur in TNF receptor deficient mice, suggesting that TNF is essential for mast cell trafficking in neurogenic cystitis. Since TNF is also a potent mediator of apoptosis, we examined the murine neurogenic cystitis model for evidence of apoptosis. Here we demonstrate that PRV induced urothelial lesions, and correlated with diminished bladder barrier function and these processes were dependent upon intact TNF signaling mediated primarily by TNF receptor 1 (TNFR1). The data suggest that therapies targeting TNF signaling may stabilize the urothelial permeability barrier and thereby reduce symptoms in IC patients.
MATERIALS AND METHODS

Animals
Female, 4-6 week old, mice with targeted deletion of TNFR1 ( 
Induction of Neurogenic Cystitis
PRV was prepared and titred as previously reported (8) . (1:1000; Molecular Probes, Carlsbad, CA). Slides were stained with DAPI, and images were acquired using a Nikon E800 microscope equipped with a Spot Color RT camera (Diagnostic Instruments, Sterling Heights, MI).
Cell culture
The PD07i cell line was established by generating primary urothelial cultures from a pediatric bladder specimen, followed by immortalization with HPV16 E6E7, as previously described (27, 32) . PD07i, PD08i, TEU-1 (21), and TEU-2 
Annexin-V staining
PD07i cells were cultured in chambered slides (Nunc, Rochester, NY) and stimulated with 10, and 1000 ng/ml recombinant TNF (Biosource, Camarillo, CA) at 37 o C for 24h.
Apoptosis was assessed using Annexin-V-FLUOS staining kit (Roche Diagnostics) according to manufacturer's protocol. Images were acquired using a Nikon E800 microscope equipped with a Spot Color RT camera.
Caspase-3 activity assay
PD07i cells were stimulated with 0.1GM staurosporine for 2h (Calbiochem, La Jolla, CA) or 10 and 100 ng/ml TNF at 37 o C for 24h. Urothelial cells were lysed with RIPA buffer containing protease inhibitors, and protein concentrations were determined by BCA.
Twenty micrograms whole cell extract was added to caspase assay buffer (100mM HEPES, 0.1% CHAPS, 1% sucrose, 2mM DTT) containing 50 GM caspase-3 substrate, Ac-DEVD-AFC (AFC-138; MP Biomedicals, Irvine, CA). Caspase-3 activity was quantified by determining the rate of cleavage of the fluorogenic substrate using a SpectraMax fluorimeter (400 nm excitation, 505 nm emission). (Invitrogen), supernatants were collected and used to infect PA 317 cells, and final supernatants containing amphotrophic virus were used to infect PD07i cells followed by selection in 1Gg/ml puromycin to create stable cell lines. Silencing of TNFR1, TNFR2, and luciferase gene expression was confirmed by western blotting. The resulting stable cell lines that targeted the silencing of TNFR1, TNFR2, and luciferase expression were designated as PD07siTNFR1, PD07siTNFR2, and PD07siLuc, respectively.
TNFR1 and TNFR2 gene silencing
IL-8 ELISA
PD07i cell were stimulated with two doses (1 and 2 Gg/ml) of TNFR1 and TNFR2 coverslipped. To determine mast cell numbers, the bladder cross-sections were divided visually into four layers: urothelium (U), lamina propria (LP), proximal half of the detrusor muscle relative to the bladder lumen (D1), and the distal half of the detrusor relative to the bladder lumen (D2) and mast cells were quantified from two non-adjacent sections (9) . All values were reported as the mean of sections for each animal.
Statistical Analysis
The results are expressed as mean ± standard deviation from three or more independent samples. When data from more than two groups were compared, the results were analyzed for statistical significance by one-way ANOVA followed by a posttest comparison using either Bonferroni's or Tukey's Multiple Comparison Test. A value of p < 0.05 was considered statistically significant. expressing lower levels of TNFR proteins ( Fig. 2A) .
RESULTS
Neurogenic
We next examined whether TNF acted directly to elicit an urothelial apoptotic response by staining for annexin-V, a marker for early apoptosis (11, 16) . These physiologic data are also consistent with the microscopic data indicating a requirement for TNF signaling in the formation of urothelial lesions (Table 1) .
TNFR1 signaling mediates decreased bladder barrier function.
To further characterize the requirements for TNF-dependent loss of barrier function, we examined the effects of PRV on TER in wild-type, TNFR1 
TABLES
